|
DENND1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64789999926407E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.36300000361945E-08 |
| Normal-vs-Stage2 |
1.9225699999903E-05 |
| Normal-vs-Stage3 |
1.69570000041475E-07 |
| Normal-vs-Stage4 |
1.017490E-03 |
| Stage1-vs-Stage2 |
5.545000E-01 |
| Stage1-vs-Stage3 |
4.995200E-01 |
| Stage1-vs-Stage4 |
7.239600E-01 |
| Stage2-vs-Stage3 |
9.305600E-01 |
| Stage2-vs-Stage4 |
4.911600E-01 |
| Stage3-vs-Stage4 |
4.719000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.31079999965422E-07 |
| Normal-vs-AfricanAmerican |
7.863900E-02 |
| Normal-vs-Asian |
2.64600000021709E-07 |
| Caucasian-vs-AfricanAmerican |
1.059390E-01 |
| Caucasian-vs-Asian |
2.752200E-01 |
| AfricanAmerican-vs-Asian |
2.939500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29170005194845E-09 |
| Normal-vs-Female |
5.0120999994796E-07 |
| Male-vs-Female |
5.404200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.44980000028295E-07 |
| Normal-vs-Age(41-60Yrs) |
1.67920000126998E-08 |
| Normal-vs-Age(61-80Yrs) |
6.21330000000198E-05 |
| Normal-vs-Age(81-100Yrs) |
4.162300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.216800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.680400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.842400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.680000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.991400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.042000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.483800E-02 |
| Classical-VS-Follicular |
1.275950E-02 |
| Classical-VS-Other |
5.575700E-03 |
| Classical-VS-Normal |
1.60067999999125E-05 |
| Tall-VS-Follicular |
8.444800E-01 |
| Tall-VS-Other |
1.118600E-01 |
| Tall-VS-Normal |
3.92680000005363E-06 |
| Follicular-VS-Other |
2.290200E-01 |
| Follicular-VS-Normal |
9.43959999055721E-09 |
| Other-VS-Normal |
2.029600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.98530003126774E-09 |
| Normal-vs-N1 |
1.52090000005156E-06 |
| N0-vs-N1 |
9.132400E-01 |
|
|
